GL1X · GenesisL1 explorer

Research workbench

Crystal structure of thrombin in complex with a novel bicyclic lactam inhibitor

Analyse Crystal structure of thrombin in complex with a novel bicyclic lactam inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1JWT
Type
protein
Length
299 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Prothrombin
EC
3.4.21.5
UniProt
P00734
Ligands
BLI
Pockets
2 · best druggability 0.59

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProthrombin (EC 3.4.21.5)protein29914% helix, 29% strandP00734

Ligands and binding sites

  • BLI · 4-oxo-2-phenylmethanesulfonyl-octahydro-pyrrolo[1,2-a]pyrazine-6-carboxylic acid [1-(N-hydroxycarbamimidoyl)-piperidin-4-ylmethyl]-amide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12990.590.7842BLI
2510.280.7515empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 1JWT · Crystal structure of thrombin in complex with a novel bicyclic lactam inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.